Printer-friendly version

Hugh Bigg


Presidential Scholars - Hugh BiggSynthesizing a Derivative of the Anti-Cancer Drug DW2282

Dr. Anthony Molinero, Advisor

The goal of my project is to successfully synthesize derivatives of an anti-cancer drug in the class Diarylsulfonylurea called DW2282. This drug has shown great promise for killing cancer cells in the past, having an activity similar to that of Taxol's (currently being used today).

By synthesizing DW2282 I hope to modify its structure in order to create a derivative with greater activity, thereby making a cancer drug that is easier and cheaper to make than Taxol.